Is Crescent Biopharma, Inc. (CBIO) a Buy, Sell, or Hold?
Crescent Biopharma, Inc.
NASDAQ:CBIO
$15.305 USD
-$0.39 (-2.45%)
- Volume
- 77.93K
- Average Volume
- 319.62K
- Market Capitalization
- $421.99M
- P/E Ratio
- -1.40
- Dividend Yield
- 0.00%
- Price Target
- $35.00
- Year High
- $27.41
- Year Low
- $8.72
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.78
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-56.3% DOWNSIDE
$35.00 Price Target
UPSIDE/DOWNSIDE HIGH
-56.3% DOWNSIDE
$35.00 Price Target High
UPSIDE/DOWNSIDE LOW
-47.2% DOWNSIDE
$29.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stifel Nicolaus | Stephen Willey | $29 | $12.345 | 2026-02-26 03:52 PM | 134.9% |
| Guggenheim | Brad Canino | $35 | $13.98 | 2026-01-21 06:34 AM | 150.4% |
| Stifel Nicolaus | Stephen Willey | $32 | $12.99 | 2025-12-04 03:32 PM | 146.3% |